Standout Papers

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syn... 2020 2026 2022 2024532
  1. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? (2020)
    Bingwen Liu, Min Li et al. Journal of Autoimmunity

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Osteoarthritis
2025 Standout
Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
2025 Standout
1 intermediate paper

Works of Xuan Guan being referenced

Dapagliflozin attenuates pressure overload-induced myocardial remodeling in mice via activating SIRT1 and inhibiting endoplasmic reticulum stress
2021
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
2020 Standout

Author Peers

Author Last Decade Papers Cites
Xuan Guan 604 274 165 392 49 1.4k
Ashok Kumar 633 164 234 164 53 1.6k
Carmen M. Halabi 560 123 283 527 35 1.7k
Xiaopeng Li 465 252 188 120 43 1.5k
Susana Boluda 402 136 145 183 53 1.4k
Emily J. Tsai 761 198 555 177 24 1.5k
Zitong Huang 338 124 56 260 73 1.1k
Wenjie Yang 169 169 194 138 61 1.2k
Yunxia Zhang 441 126 75 117 71 1.2k
Savalan Babapoor-Farrokhran 379 57 335 323 33 1.2k
Weiwei Xu 654 270 105 152 84 1.7k

All Works

Loading papers...

Rankless by CCL
2026